SITC gratefully acknowledges the following supporters of the society's 34th Annual Meeting & Pre-Conference Programs.
34th Annual Meeting
Double Platinum
AstraZeneca Pharmaceuticals LP
Platinum
Bristol-Myers Squibb
Incyte Corporation
Merck & Co., Inc.
Gold
AbbVie
Amgen
Genentech
TESARO, Inc.
Silver
Eli Lilly and Company
Gilead Sciences, Inc.
Janssen Research & Development, LLC
Novartis Pharmaceuticals
Bronze
Bayer
Celgene Corporation
NanoString Technologies
(The CheckPoints Party)
Pfizer, Inc.
Seattle Genetics, Inc.
Copper
7 Hills Pharma, LLC
(The CheckPoints Party)Fluidigm Corporation
(The CheckPoints Party)
HalioDx
(The CheckPoints Party)
Primer on Tumor Immunology and Cancer Immunotherapy
Silver
Merck & Co., Inc.
Bronze
Bristol-Myers Squibb
Celgene Corporation
Genentech
Copper
Pfizer, Inc.
Workshop on Intratumoral Immunomodulation
Bronze
Amgen
Celgene Corporation
Idera Pharmaceuticals
Copper
Pfizer, Inc.
Industry Program: Novel Multi-Targeted Therapeutic Platforms
Gold
Bristol-Myers Squibb
Silver
AstraZeneca Pharmaceuticals LP
Gilead Sciences, Inc.
Merck & Co., Inc.
Copper
Celgene Corporation
Pfizer, Inc.
World Immunotherapy Council's 3rd Young Investigator Symposium on Cancer Immunotherapy
Silver
Bristol-Myers Squibb
Bronze
Merck & Co., Inc.
Copper
Celgene Corporation
Pfizer, Inc.
Grant Writing Workshop: The study section black box: A look inside the grant review process
Bronze
Merck & Co., Inc.